Director, Global Value & Access HIV Execution - ICR

Job Description

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Key Responsibilities

Reporting to the Senior Director, Global Value & Access Strategy HIV Treatment, our Director of GV&A HIV Execution – ICR midsize markets will:

• Partner closely with ICR market teams to adapt and drive execution of GV&A strategies and launch plans to optimize access, reimbursement and uptake of HIV franchise products (both HIV Treatment and Prevention), aligned to local needs.

• Partner closely with cross-functional teams to develop and implement awareness of unmet needs, HIV product value propositions and health economic tools to support HIV value demonstration and differentiation.

• Lead the implementation of new capabilities, including Value Strategy & Realization (VS&R), tailored to local requirements and opportunities in collaboration with the GV&A triad and the GV&A Capabilities & Execution Lead. to ensure understanding of strategy, disease/product data, managing payer objections including negotiation skills for successful launch execution.

• Support V&A stakeholder engagement plans across ICR market affiliates, develop engagement objectives and tools to monitor activities and KPIs.

• Support payer research and insights generation (as needed) to understand HIV product value perception, V&A landscape trends, value drivers and test value messages.

• Provide the ICR market regional perspective and champion local market’s needs into development of GV&A strategies and materials.

Knowledge, Skills and Experience

We’re seeking a strategic, influential leader with the following:

• At least 12+ years’ experience in the biotech or pharmaceutical industry in market access-related activities with a Bachelors degree OR 10 + years’ experience in the biotech or pharmaceutical industry in market access-related activities with a MS/MA degree OR 8 + years’ experience in the biotech or pharmaceutical industry in market access-related activities with a PhD.

• Experience in regional/country market access, launch planning and execution is required, experience within the ICR region is preferred although not required.

• HIV disease area experience and market knowledge an advantage

• Strong understanding of payer environment, including HTA, pricing and reimbursement, contracting and negotiation, and policy development

• Experience developing V&A strategies and dossier submissions, including value messages, HEOR models and tools to support implementation in key markets

• Demonstrated ability to lead and influence across functions and levels in a matrix environment: skilled facilitator, communicator and strategic thinker

• Ability to engage and manage multiple stakeholders to achieve the objective

• Curious with learning agility; Operationally excellent

We are pleased to share that Gilead’s Stockley Park and Holborn offices are planning to come together at a new London headquarters at 1 Triton Square, NW1, from approximately Q2 2027. Applicants should consider this planned location change when applying for this role. Gilead operates a flexible working policy, offering a balanced approach with two days of remote working and three days working onsite.

Equal Employment Opportunity (EEO)

It is the policy of Gilead Sciences, Inc. and its subsidiaries and affiliates (collectively "Gilead" or the "Company") to recruit select and employ the most qualified persons available for positions throughout the Company.  Except if otherwise provided by applicable law, all  employment actions relating to issues such as compensation, benefits, transfers, layoffs, returns from layoffs, company-sponsored training, education assistance, social and recreational programs are administered on a non-discriminatory basis (i.e. without regard to protected characteristics or prohibited grounds, which may include an individual’s gender, race, color, national origin, ancestry, religion, creed, physical or mental disability, marital status, sexual orientation, medical condition, veteran status, and age, unless such protection is prohibited by federal, state, municipal, provincial, local or other applicable laws).  Gilead also prohibits discrimination based on any other characteristics protected by applicable laws.

For Current Gilead Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.